First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.

Thirty-one consecutive patients with advanced epithelial ovarian cancer entered a phase II study with cisplatin and etoposide combination chemotherapy. None of them had received prior chemotherapy or radiotherapy. Most patients had advanced (88%) or far advanced (61%) disease. All 31 patients are ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanassiou, A. E., Bafaloukos, D., Pectasides, D., Dimitriadis, M., Varthalitis, I., Barbounis, V.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247295/
https://www.ncbi.nlm.nih.gov/pubmed/2803952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247295/
https://www.ncbi.nlm.nih.gov/pubmed/2803952

Ejemplares similares